NASDAQ
Castle Biosciences, Inc. (CSTL) has a free cash flow growth of -275.14% as of Friday, May 29, 2026. This represents a 771.76% decrease compared to its 12-month average of 40.96%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.